Venture CapitalRIA · CRD 341187SEC-RegisteredPrivate Fund Adviser

Updated:

W Health Ventures

W Health Ventures, led by Gaurav Tewari and John Ryan, deploys early-stage capital into digital-health companies from Pittsburgh since 2019.

W Health Ventures logo

W Health Ventures

W Health Ventures is an SEC-registered investment adviser, registered since 2026. It advises on investment strategies. The firm is based in the United States.

General information

Firm type

Venture Capital

Year founded

2019

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Pittsburgh

Corporate office

Pittsburgh, PA, United States

Principals

Gaurav Tewari

Managing Partner

John F. Ryan

Managing Partner

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

Who runs investment decisions at W Health Ventures?

Managing Partners Gaurav Tewari and John F. Ryan jointly oversee investment decisions. Both held strategy and venture roles at Cardinal Health prior to founding the firm in 2019, giving them direct experience in healthcare distribution, payer dynamics, and hospital system operations. The firm operates with a partnership structure where the two managing partners share investment committee responsibilities.

How does W Health Ventures source proprietary deal flow?

The firm sources through a structured network of health-system executives, Cardinal Health alumni, and regional payer leadership. Its Pittsburgh location provides exposure to community-hospital innovation priorities that coastal venture firms often miss. The firm also maintains relationships with academic medical centers in the Midwest and mid-Atlantic regions, where clinical champions identify early-stage companies in need of validation capital.

Is W Health Ventures structured as a single family office or does it operate more like a venture firm?

W Health Ventures operates as a traditional venture capital firm, not a family office. It raises capital from limited partners and deploys it into early-stage digital-health companies. The firm is led by two managing partners with operating backgrounds at Cardinal Health and follows a standard venture fund structure with management fees and carried interest, though specific fund terms remain undisclosed.

Does W Health Ventures participate in fund commitments or only direct deals?

W Health Ventures invests exclusively through direct equity positions in early-stage digital-health companies. Public records indicate no activity as a fund-of-funds investor or allocator to other venture managers. The firm's strategy relies on hands-on portfolio support, which limits the utility of indirect fund commitments.

What investment stages does W Health Ventures typically target?

The firm targets Seed and Series A rounds with initial check sizes appropriate to early-stage digital-health companies, per its own public positioning. It selectively participates in follow-on rounds as portfolio companies reach growth stages. The firm has not publicly disclosed its typical initial check range or reserve allocation strategy.

How is W Health Ventures related to Cardinal Health?

Both managing partners, Gaurav Tewari and John F. Ryan, previously held senior strategy and venture roles at Cardinal Health. W Health Ventures operates independently of Cardinal Health—it is not a corporate venture arm or captive fund. However, the alumni relationship provides portfolio companies informal access to pharmaceutical wholesale and hospital-supply-chain expertise relevant to scaling healthcare startups.

What is W Health Ventures' known posture on co-investments alongside external GPs?

The firm regularly participates in syndicates alongside generalist venture funds and healthcare-specialist investors. Public records suggest W Health often serves as the sector-specific co-investor within broader funding rounds, contributing healthcare-operations diligence that generalist GPs lack internally. The firm does not require board seats in every deal—its involvement is calibrated to each portfolio company's governance needs.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Pittsburgh Venture Capital profiles